This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Alzeca Biosciences, LLC, Texas Children's Hospital. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 11 
Years Active: 2023
Title: Xianwei Sun: Innovator in MRI Contrast Agents
Introduction
Xianwei Sun is a notable inventor based in Houston, Texas. He has made significant contributions to the field of medical imaging, particularly in the development of targeted contrast agents for MRI.
Latest Patents
Xianwei Sun holds a patent for "Targeted contrast agents for MRI of alpha-synuclein deposition." This invention, known as ADx-003, is a liposomal composition that includes a first phospholipid, a sterically bulky excipient for stabilization, and a macrocyclic gadolinium-based imaging agent. The composition is designed to enhance imaging capabilities for detecting alpha-synuclein deposition, which is crucial in diagnosing certain neurodegenerative diseases.
Career Highlights
Throughout his career, Xianwei Sun has worked with prominent organizations such as Texas Children's Hospital and Alzeca Biosciences, LLC. His work in these institutions has allowed him to advance his research and contribute to innovative solutions in medical imaging.
Collaborations
Xianwei has collaborated with notable colleagues, including Eric A Tanifum and Ananth V Annapragada. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.
Conclusion
Xianwei Sun's contributions to the field of MRI contrast agents exemplify his dedication to innovation in medical imaging. His work continues to pave the way for advancements that can significantly impact patient diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile